A CASE OF SYSTEMIC SCLEROSIS SINE SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE WITHOUT A POSITIVE ANA?

被引：0
|
作者：
Djondo, Daniel
机构：
来源：
CHEST | 2018年 / 154卷 / 04期
关键词：
D O I：
10.1016/j.chest.2018.08.861
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：957A / 957A
页数：1
相关论文
共 50 条
  • [1] Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease
    Fischer, Aryeh
    Meehan, Richard T.
    Feghali-Bostwick, Carol A.
    West, Sterling G.
    Brown, Kevin K.
    CHEST, 2006, 130 (04) : 976 - 981
  • [2] INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SINE SCLERODERMA SYSTEMIC SCLEROSIS: A CASE PRESENTATION
    Veltri, I.
    Bilder, C.
    Ditaranto, A.
    Mela, M.
    Baldessari, E.
    Caneva, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S111 - S112
  • [3] Clinical features of scleroderma sine scleroderma-associated progressive interstitial lung disease.
    Fischer, A
    Cosgrove, GP
    Collard, HR
    Feghali-Bostwick, CA
    Loucks, J
    West, SG
    Meehan, RT
    Brown, KK
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S589 - S589
  • [4] Update on scleroderma-associated interstitial lung disease
    Fan, Ming-Hui
    Feghali-Bostwick, Carol A.
    Silver, Richard M.
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (06) : 630 - 636
  • [5] Effect Of Mycophenolate Mofetil On Scleroderma-Associated Interstitial Lung Disease
    Baqir, M.
    Makol, A.
    Osborn, T. G.
    Bartholmai, B.
    Ryu, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [6] A New Era in the Treatment of Scleroderma-associated Interstitial Lung Disease?
    Launay, David
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (09) : 1619 - 1621
  • [7] SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD)
    Silver, R.
    RHEUMATOLOGY, 2012, 51 : I12 - I12
  • [8] A Rare Case of Anti-RNA Polymerase III Autoantibody-Associated Interstitial Lung Disease in Systemic Sclerosis Sine Scleroderma
    Tam, W.
    Nambiar, A. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [9] Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease
    Silver, R. M.
    Wilson, D. A.
    Akter, T.
    Atanelishvili, I.
    Huggins, J. T.
    Kajdasz, K.
    Highland, K. B.
    Nietert, P. J.
    Bogatkevich, G. S.
    ACR OPEN RHEUMATOLOGY, 2019, 1 (07) : 403 - 411
  • [10] Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab
    McGonagle, D.
    Tan, A. L.
    Madden, J.
    Rawstron, A. C.
    Rehman, A.
    Emery, P.
    Thomas, S.
    RHEUMATOLOGY, 2008, 47 (04) : 552 - 553
12345